Nemaura Medical Investor Presentation Deck

sugarBEATⓇ Regulatory Status ■ ● CE Approved Class 2b Medical Device in Europe FDA PMA submitted and in review FDA Bio-monitoring Division (BIMO) Audit conducted in December 2021 at Nemaura's UK facility. A single 483 observation was issued. Company submitted a full and complete response to FDA in January 2022. • FDA Pre-market inspection covering FDA's Quality System/Current Good Manufacturing Practice regulations for Medical Devices (21 CFR Part 820) completed in Q2 2022. Full response sent and company continues dialogue in relation to the application. Further updates to be provided in due course.

View entire presentation